Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

324 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mobile Health Projects in a High-Complexity Reference Hospital: Case Study.
Grau-Corral I, Jansà M, Gascon P, Lozano-Rubí R, Pantoja PE, Roca D, Aragunde Miguens V, Hidalgo-Mazzei D, Escarrabill J. Grau-Corral I, et al. Among authors: gascon p. JMIR Mhealth Uhealth. 2020 Jan 31;8(1):e16247. doi: 10.2196/16247. JMIR Mhealth Uhealth. 2020. PMID: 32012092 Free PMC article.
Role of semaphorins, neuropilins and plexins in cancer progression.
Fernández-Nogueira P, Linzoain-Agos P, Cueto-Remacha M, De la Guia-Lopez I, Recalde-Percaz L, Parcerisas A, Gascon P, Carbó N, Gutierrez-Uzquiza A, Fuster G, Bragado P. Fernández-Nogueira P, et al. Among authors: gascon p. Cancer Lett. 2024 Dec 1;606:217308. doi: 10.1016/j.canlet.2024.217308. Epub 2024 Oct 28. Cancer Lett. 2024. PMID: 39490515 Free article. Review.
Transretinal puncture with a 41G cannula for posterior residual subretinal fluid in fovea-off retinal detachments treated by vitrectomy VS fluid tolerance VS other conventional drainage techniques: a comparative study.
Desira M, Ruiz T, Comet A, Matonti F, Conrath J, Gravier-Dumonceau R, Delaporte C, Morel C, Devin F, David T, Gascon P. Desira M, et al. Among authors: gascon p. Retina. 2024 Oct 16. doi: 10.1097/IAE.0000000000004309. Online ahead of print. Retina. 2024. PMID: 39454073
Fully automated epicardial adipose tissue volume quantification with deep learning and relationship with CAC score and micro/macrovascular complications in people living with type 2 diabetes: the multicenter EPIDIAB study.
Gaborit B, Julla JB, Fournel J, Ancel P, Soghomonian A, Deprade C, Lasbleiz A, Houssays M, Ghattas B, Gascon P, Righini M, Matonti F, Venteclef N, Potier L, Gautier JF, Resseguier N, Bartoli A, Mourre F, Darmon P, Jacquier A, Dutour A. Gaborit B, et al. Among authors: gascon p. Cardiovasc Diabetol. 2024 Sep 3;23(1):328. doi: 10.1186/s12933-024-02411-y. Cardiovasc Diabetol. 2024. PMID: 39227844 Free PMC article.
The SEMA3F-NRP1/NRP2 axis is a key factor in the acquisition of invasive traits in in situ breast ductal carcinoma.
Moragas N, Fernandez-Nogueira P, Recalde-Percaz L, Inman JL, López-Plana A, Bergholtz H, Noguera-Castells A, Del Burgo PJ, Chen X, Sorlie T, Gascón P, Bragado P, Bissell M, Carbó N, Fuster G. Moragas N, et al. Among authors: gascon p. Breast Cancer Res. 2024 Aug 13;26(1):122. doi: 10.1186/s13058-024-01871-0. Breast Cancer Res. 2024. PMID: 39138514 Free PMC article.
Correction: ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer : Alexandra Leary.
Leary A, Estévez-García P, Sabatier R, Ray-Coquard I, Romeo M, Barretina-Ginesta P, Gil-Martin M, Garralda E, Bosch-Barrera J, Morán T, Martin-Martorell P, Nadal E, Gascón P, Rodon J, Lizcano JM, Muñoz-Guardiola P, Fierro-Durán G, Pedrós-Gámez O, Pérez-Montoyo H, Yeste-Velasco M, Cortal M, Pérez-Campos A, Alfon J, Domenech C, Pérez-Fidalgo A, Oaknin A. Leary A, et al. Among authors: gascon p. BMC Cancer. 2024 Jul 29;24(1):911. doi: 10.1186/s12885-024-12700-0. BMC Cancer. 2024. PMID: 39075404 Free PMC article. No abstract available.
ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer.
Leary A, Estévez-García P, Sabatier R, Ray-Coquard I, Romeo M, Barretina-Ginesta P, Gil-Martin M, Garralda E, Bosch-Barrera J, Morán T, Martin-Martorell P, Nadal E, Gascón P, Rodon J, Lizcano JM, Muñoz-Guardiola P, Fierro-Durán G, Pedrós-Gámez O, Pérez-Montoyo H, Yeste-Velasco M, Cortal M, Pérez-Campos A, Alfon J, Domenech C, Pérez-Fidalgo A, Oaknin A. Leary A, et al. Among authors: gascon p. BMC Cancer. 2024 Jul 22;24(1):876. doi: 10.1186/s12885-024-12501-5. BMC Cancer. 2024. PMID: 39039449 Free PMC article. Clinical Trial.
324 results